3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-1-methyl-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione | 224162-40-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-1-methyl-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione
• 英文别名: 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-1-methyl-6-trifluoromethyl-2,4(1H,3H)-pyrimidinedione；3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-1-methyl-6-(trifluoromethyl)pyrimidine-2,4-dione
• CAS: 224162-40-7
• 化学式: C₁₃H₈ClF₄N₃O₅
• 分子量: 397.67
• InChiKey: OQGKHTHNZRZBNW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  26
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  95.7
• 氢给体数：
  0
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-1-methyl-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione 、 水 在 铁粉 氮 、 水 、 Brine 、 Sodium sulfate-III 作用下， 以 溶剂黄146 为溶剂， 反应 6.0h， 以to afford the title compound (6.8 g)的产率得到3-(2-amino-4-chloro-6-fluoro-3-methoxyphenyl)-1-methyl-6-trifluoromethyl-2,4(1H,3H)-pyrimidinedione
  参考文献：
  名称：

  Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them

  摘要：

  本发明涉及一种新型的除草和落叶取代苯胺衍生物化合物，其一般结构式为（I）1。其中，W、X、Y、Z和Q的定义如所述。本发明还描述了制造这些化合物的过程以及含有这些化合物作为活性成分的农业适用组合物，这些组合物在非常低的浓度下对非期望的植物物种具有除草和落叶作用，可以用作除草剂和落叶剂的普通或选择性前期或后期控制。

  公开号：

  US20020133007A1
• 作为产物：
  描述：

  3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione 、 硫酸二甲酯 在 potassium carbonate 作用下， 以 N-甲基乙酰胺 、 水 、 乙酸乙酯 为溶剂， 生成 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-1-methyl-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione
  参考文献：
  名称：

  Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them

  摘要：

  描述了由一般结构（I）代表的新型除草剂和脱叶剂取代苯胺衍生化合物。其中，W、X、Y、Z 和 Q 如披露中所定义。还描述了制造这些化合物的过程以及含有这些化合物作为活性成分的农业适用组合物，这些组合物可作为除草剂用于一般或选择性的前期或后期控制不受欢迎的植物物种和脱叶剂，且这些生物活性化合物的浓度非常低。

  公开号：

  US06355799B1

文献信息

• Processes to prepare pyrimidinediones
  申请人：——

  公开号：US20020010334A1

  公开（公告）日：2002-01-24

  A process for the preparation of a compound of formula I 1 comprising the steps of forming an 1-unsubstituted pyrimidinedione by reacting under basic conditions either a carbamate or an isocyanate with an alkenoate and forming a compound of formula I by alkylating, aminating, haloalkylating, alkylnitrilating, arylating, allylating, alkylalkoxylating, alkylcarboxylating, or propargylating the 1-position of said unsubstituted pyrimidinedione by adding an adduct forming agent selected from the group consisting of alkylating, aminating, haloalkylating, alkylnitrilating, arylating, allylating, alkylalkoxylating, alkylcarboxylating, and propargylating agents; where the 1-unsubstituted pyrimidinedione, the carbamate, the isocyanate, the alkenoate, and substituents V, W, X, Y, Z, and R are described herein. The reactions as described herein are carried out in a single reaction vessel and often produce the pyrimidindione of formula I in near quantitative yields. It is emphasized that his abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims (see 37 C.F.R. 1.72(b)).

  一种制备I式化合物的方法，包括以下步骤：在碱性条件下，通过将碳酸酯或异氰酸酯与烯酸酯反应形成1-未取代嘧啶二酮，然后通过烷基化、氨基化、卤代烷基化、烷基腈化、芳基化、烯丙基化、烷基烷氧基化、烷基羧基化或丙炔基化1-位置上的未取代嘧啶二酮形成I式化合物，通过添加从烷基化、氨基化、卤代烷基化、烷基腈化、芳基化、烯丙基化、烷基烷氧基化、烷基羧基化或丙炔基化试剂组成的加合物形成剂进行。其中，所述1-未取代嘧啶二酮、碳酸酯、异氰酸酯、烯酸酯和取代基V、W、X、Y、Z和R如本文所述。所述的反应在单个反应容器中进行，并且通常以接近定量产率产生I式嘧啶二酮。强调此摘要是为了遵守要求提供一个允许搜索者或其他读者快速确定技术披露主题的摘要的规则。提交此摘要时应理解，它不会被用来解释或限制权利要求的范围或含义（参见37 C.F.R. 1.72(b)）。
• [DE] HERBIZIDE 3-(BENZAZOL-4-YL)PYRIMIDINDION-DERIVATE<br/>[EN] HERBICIDES 3-(BENZAZOL-4-YL)PYRIMIDINE-DIONE-DERIVATIVES<br/>[FR] DERIVES DE 3-(BENZAZOL-4-YLE)DIONE DE PYRIMIDINE HERBICIDES
  申请人：BASF AKTIENGESELLSCHAFT

  公开号：WO1999031091A1

  公开（公告）日：1999-06-24

  (DE) 3-(Benzazol-4-yl)pyrimidindion-Derivate der Formel (I) und deren Salze, wobei X = O, S; R1 = H, NH2, C1-C6-Alkyl, C1-C6-Halogenalkyl; R2 = H, Halogen, C1-C6-Alkyl, C1-C6-Halogenalkyl, C1-C6-Alkylthio, C1-C6-Alkylsulfinyl, C1-C6-Alkylsulfonyl; R3 = H, Halogen, C1-C6-Alkyl; R4 = H, Halogen; R5 = CN, Halogen, C1-C6-Alkyl, C1-C6-Halogenalkyl, C1-C6-Alkoxy, C1-C6-Halogenalkoxy; =Y- = eine Gruppe =N-N(R6)-, =C(ZR7)-N(R6)-, =C(ZR7)-O-, =C(ZR7)-S-; R6 = C1-C6-Alkyl, C1-C4-Halogenalkyl, C3-C6-Cycloalkyl, C3-C6-Alkenyl, C3-C6-Alkinyl, C1-C6-Alkyl-SO2, C1-C6-Alkyl-CO, C1-C6-Halogenalkyl-CO, C1-C6-Alkyl-CS, C1-C6-Alkoxy-CO, C1-C6-Alkoxy-CS oder gegebenenfalls substituiertes C1-C6-Alkyl; Z = chemische Bindung, O, S, -S(O)-, -SO2-, -NH-, -N(R8)-; R7, R8 = C1-C6-Alkyl, C1-C6-Halogenalkyl, Hydroxy-C1-C4-alkyl, Cyano-C1-C4-alkyl, C1-C4-Alkoxy-C1-C4-alkyl, C1-C4-Halogenalkoxy-C1-C4-alkyl, C3-C4-Alkenyloxy-C1-C4-alkyl, C3-C4-Alkinyloxy-C1-C4-alkyl, C3-C8-Cycloalkoxy-C1-C4-alkyl, Amino-C1-C4-alkyl, C1-C4-Alkylamino-C1-C4-alkyl, Di(C1-C4-alkyl)amino-C1-C4-alkyl, C1-C4-Alkylthio-C1-C4-alkyl, C1-C4-Halogenalkylthio-C1-C4-alkyl, C3-C4-Alkenylthio-C1-C4-alkyl, C3-C4-Alkinylthio-C1-C4-alkyl, C1-C4-Alkylsulfinyl-C1-C4-alkyl, C1-C4-Halogenalkylsulfinyl-C1-C4-alkyl, C3-C4-Alkenylsulfinyl-C1-C4-alkyl, C3-C4-Alkinylsulfinyl-C1-C4-alkyl, C1-C4-Alkylsulfonyl-C1-C4-alkyl, C1-C4-Halogenalkylsulfonyl-C1-C4-alkyl, C3-C4-Alkenylsulfonyl-C1-C4-alkyl, C3-C4-Alkinylsulfonyl-C1-C4-alkyl, C3-C6-Alkenyl, Cyano-C3-C6-alkenyl, C3-C6-Halogenalkenyl, C3-C6-Alkinyl, Cyano-C3-C6-alkinyl, C3-C6-Halogenalkinyl, HO-CO-C1-C4-alkyl, (C1-C4-Alkoxy)CO-C1-C4-alkyl, (C1-C4-Alkyl-)CS-C1-C4-alkyl, H2N-CO-C1-C4-alkyl, C1-C4-Alkyl-NHCO-C1-C4-alkyl, Di(C1-C4-alkyl)NCO-C1-C4-alkyl, Di(C1-C4-alkyl)phosphonyl-C1-C4-alkyl, gegebenenfalls substituiertes C3-C8-Cyclo-alkyl, C3-C8-Cycloalkyl-C1-C4-alkyl, Phenyl, Phenyl-C1-C4-alkyl, 3- bis 7-gliedriges Heterocyclyl oder Heterocyclyl-C1-C4-alkyl, wobei jeder Heterocyclyl-Ring ein CO- oder CS-Ringglied enthalten kann, oder, sofern Z = chemische Bindung, R7 auch H, OH, CN, SH, NH2, Halogen, -CH(OH)-CH2-R9, -CH(Halogen)-CH2-R9, -CH2-CH(Halogen)-R9, -CH=CH-R9 oder -CH=C(Halogen)-R9, wobei R9 = COOH, (C1-C4-Alkoxy)carbonyl, (C1-C4-Alkythio)carbonyl, CONH2, C1-C4-Alkyl-NHCO oder Di(C1-C4-alkyl)NCO, oder R7 + R8 = gegebenenfalls substituierte 1,3-Propylen- ,Tetramethylen-, Pentamethylen- oder Ethylenoxyethylen-Kette.(EN) The invention relates to 3-(benzazol-4-yl)pyrimidine-dione-derivatives of formula (I) and the salts thereof, whereby X = O, S; R1 = H, NH2, C1-C6-alkyl, C1-C6-alkyl halide; R2 = H, halogen, C1-C6-alkyl, C1-C6-alkyl halide, C1-C6-alkylthio, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl; R3 = H, halogen, C1-C6-alkyl; R4 = H, halogen; R5 = CN, halogen, C1-C6-alkyl, C1-C6-alkyl halide, C1-C6-alkoxyl, C1-C6-alkoxyl halide; =Y- = a group =N-N(R6)-, =C(ZR7)-N(R6)-, =C(ZR7)-O-, =C(ZR7)-S-; R6 = C1-C6-alkyl, C1-C4-alkyl halide, C3-C6-cycloalkyl, C3-C6-alkenyl, C3-C6-alkynyl, C1-C6-alkyl-SO2, C1-C6-alkyl-CO, C1-C6-alkyl halide-CO, C1-C6-alkyl-CS, C1-C6-alkoxyl-CO, C1-C6-alkoxyl-CS or optionally substituted C1-C6-alkyl; Z = chemical bond, O, S, -S(O)-, -SO2-, -NH-, -N(R8)-; R7, R8 = C1-C6-alkyl, C1-C6-alkyl halide, hydroxy-C1-C4-alkyl, cyano-C1-C4-alkyl, C1-C4-alkoxyl-C1-C4-alkyl, C1-C4-alkoxyl halide-C1-C4-alkyl, C3-C4-alkenyloxyl-C1-C4-alkyl, C3-C4-alkynyloxyl-C1-C4-alkyl, C3-C8-cycloalkoxyl-C1-C4-alkyl, amino-C1-C4-alkyl, C1-C4-alkylamino-C1-C4-alkyl, di(C1-C4-alkyl)amino-C1-C4-alkyl, C1-C4-alkylthio-C1-C4-alkyl, C1-C4-alkylthio halide-C1-C4-alkyl, C3-C4-alkenylthio-C1-C4-alkyl, C3-C4-alkynylthio-C1-C4-alkyl, C1-C4-alkylsulfinyl-C1-C4-alkyl, C1-C4-alkylsulfinyl halide-C1-C4-alkyl, C3-C4-alkenylsulfinyl-C1-C4-alkyl, C3-C4-alkynylsulfinyl-C1-C4-alkyl, C3-C6-alkenyl, cyano-C3-C6-alkenyl, C3-C6-alkenyl halide, C3-C6-alkynyl, cyano-C3-C6-alkynyl, C3-C6-alkynyl halide, HO-CO-C1-C4-alkyl, (C1-C4-alkoxyl)CO-C1-C4-alkyl, (C1-C4-alkyl)CS-C1-C4-alkyl, H2N-CO-C1-C4-alkyl, C1-C4-alkyl-NHCO-C1-C4-alkyl, di(C1-C4-alkyl)NCO-C1-C4-alkyl, di(C1-C4-alkyl)phosphonyl-C1-C4-alkyl, optionally substituted C3-C8-cycloalkyl, C3-C8-cycloalkyl-C1-C4-alkyl, phenyl, phenyl-C1-C4-alkyl, 3- to 7-linked heterocyclyl or heterocyclyl-C1-C4-alkyl, whereby each heterocyclyl ring can contain a CO-ring link or CS-ring link, or provided that Z = chemical bond, R7 also H, OH, CN, SH, NH2, halogen, -CH(OH)-CH2-R9, -CH(halogen)-CH2-R9, -CH2-CH(halogen)-R9, -CH=CH-R9 or -CH=C(halogen)-R9, whereby R9 = COOH, (C1-C4-alkoxyl)carbonyl, (C1-C4-alkylthio)carbonyl, CONH2, C1-C4-alkyl-NHCO or di(C1-C4-alkyl)NCO, or R7 + R8 = an optionally substituted 1,3-propylene-, tetramethylene-, pentamethylene- or ethylene oxyethylene-chain.(FR) L'invention concerne des dérivés 3-(benzazol-4-yle)dione de pyrimidine de la formule (I) et leurs sels. Dans cette formule, X = O, S; R1 = H, NH2, alkyle C1-C6, halogénure d'alkyle C1-C6; R2 = H, halogène, alkyle C1-C6, halogénure d'alkyle, alkylthio C1-C6, alkylsulfinyle C1-C6, alkylsulfonyle C1-C6; R3 = H, halogène, alkyle C1-C6; R4 = H, halogène; R5 = CN, halogène, alkyle C1-C6, halogénure d'alkyle C1-C6, alcoxy C1-C6, halogénure d'alcoxy C1-C6; =Y- = un groupe =N-N(R6)-, =C(ZR7)-N(R6)-, =C(ZR7)-O-, =C(ZR7)-S-; R6 = alkyle C1-C6, halogénure d'alkyle C1-C4, cycloalkyle C3-C6, alkényle C3-C6, alkinyle C3-C6, alkyle C1-C6-SO2, alkyle C1-C6-CO, halogénure d'alkyle C1-C6-CO, alkyle C1-C6-CS, alcoxy C1-C6-CO, alcoxy C1-C6-CS ou alkyle C1-C6 éventuellement substitué; Z = liaison chimique, O, S, -S(O)-, -SO2-, -NH-, -N(R8)-; R7, R8 = alkyle C1-C6, halogénure d'alkyle C1-C6, hydroxy-alkyle C1-C4, cyano-alkyle C1-C4, alcoxy C1-C4-alkyle C1-C4, halogénure d'alcoxy C1-C4-alkyle C1-C4, alkényloxy C3-C4-alkyle C1-C4, alkinyloxy C3-C4-alkyle C1-C4, cycloalkoxy C3-C8-alkyle C1-C4, amino-alkyle C1-C4, alkylamino C1-C4-alkyle C1-C4, di(alkyle C1-C4)amino-alkyle C1-C4, alkylthio C1-C4-alkyle C1-C4, halogénure d'alkylthio C1-C4, alkénylthio C3-C4-alkyle C1-C4, alkinylthio C3-C4-alkyle C1-C4, alkylsulfinyle C1-C4-alkyle C1-C4, halogénure d'alkylsulfinyle C1-C4-alkyle C1-C4-alkénylsulfinyle C3-C4-alkyle C1-C4, alkinylsulfinyle C3-C4-alkyle C1-C4, alkylsulfonyle C1-C4-alkyle C1-C4, halogénure d'alkylsulfonyle C1-C4-alkyle C1-C4, alkénylsulfonyle C3-C4-alkyle C1-C4, alkinylsulfonyle C3-C4-alkyle C1-C4, alkényle C3-C6, cyano-alkényle C3-C6, halogénure d'alkényle C3-C6, alkinyle C3-C6, cyano-alkinyle C3-C6, halogénure d'alkinyle C3-C6, HO-CO-alkyle C1-C4, (alcoxy C1-C4)CO-alkyle C1-C4, (alkyle C1-C4)CS-alkyle C1-C4, H2N-CO-alkyle C1-C4, alkyle C1-C4-NHCO-alkyle C1-C4, di(alkyle C1-C4)NCO-alkyle C1-C4, di(alkyle C1-C4)phosphonyle-alkyle C1-C4, cycloalkyle C3-C8 éventuellement substitué, cycloalkyle C3-C8-alkyle C1-C4, phényle, phényle-alkyle C1-C4, hétérocyclyle ayant entre 3 et 7 chaînons ou hétérocyclyle-alkyle C1-C4, chaque composé hétérocyclyle pouvant contenir un chaînon cyclique CS, ou si Z = liaison chimique, R7 désigne également H, OH, CN, SH, NH2, halogène, -CH(OH)-CH2-R9, -CH(halogène)-R9, R9 = COOH, (alcoxy C1-C4)carbonyle, (alkylthio C1-C4)carbonyle, CONH2, alkyle C1-C4-NHCO ou di(alkyle C1-C4)NCO, ou R7 + R8 = chaîne de 1,3-propylène-tétraméthylène, de pentaméthylène ou d'oxyéthylène d'éthylène, éventuellement substituée.

  （DE）本发明涉及具有式（I）的3-(苯并杂环-4-基)嘧啶二酮衍生物及其盐，其中X=O，S；R₁=H，NH₂，C₁-C₆烷基，C₁-C₆卤代烷基；R₂=H，卤素，C₁-C₆烷基，C₁-C₆卤代烷基，C₁-C₆烷硫基，C₁-C₆亚磺酰基，C₁-C₆磺酰基；R₃=H，卤素，C₁-C₆烷基；R₄=H，卤素；R₅=CN，卤素，C₁-C₆烷基，C₁-C₆卤代烷基，C₁-C₆烷氧基，C₁-C₆卤代烷氧基；=Y-为=N-N(R₆)-，=C(ZR₇)-N(R₆)-，=C(ZR₇)-O-，=C(ZR₇)-S-；R₆=C₁-C₆烷基，C₁-C₄卤代烷基，C₃-C₆环烷基，C₃-C₆烯基，C₃-C₆炔基，C₁-C₆烷基-SO₂，C₁-C₆烷基-CO，C₁-C₆卤代烷基-CO，C₁-C₆烷基-CS，C₁-C₆烷氧基-CO，C₁-C₆烷氧基-CS或C₁-C₆烷基（任选取代）；Z=化学键，O，S，-S(O)-，-SO₂-，-NH-，-N(R₈)-；R₇，R₈=C₁-C₆烷基，C₁-C₆卤代烷基，羟基-C₁-C₄烷基，氰基-C₁-C₄烷基，C₁-C₄烷氧基-C₁-C₄烷基，C₁-C₄卤代烷氧基-C₁-C₄烷基，C₃-C₄烯氧基-C₁-C₄烷基，C₃-C₄炔氧基-C₁-C₄烷基，C₃-C₈环烷氧基-C₁-C₄烷基，氨基-C₁-C₄烷基，C₁-C₄烷氨基-C₁-C₄烷基，二(C₁-C₄烷基)氨基-C₁-C₄烷基，C₁-C₄烷硫基-C₁-C₄烷基，C₁-C₄卤代烷硫基-C₁-C₄烷基，C₃-C₄烯硫基-C₁-C₄烷基，C₃-C₄炔硫基-C₄烷基，C₁-C₄烷亚磺基-C₁-C₄烷基，C₁-C₄卤代烷亚磺基-C₁-C₄烷基，C₃-C₄烯亚磺基-C₁-C₄烷基，C₃-C₄炔亚磺基-C₁-C₄烷基，C₁-C₄烷磺基-C₁-C₄烷基，C₁-C₄卤代烷磺基-C₁-C₄烷基，C₃-C₄烯磺基-C₁-C₄烷基，C₃-C₄炔磺基-C₁-C₄烷基，C₃-C₆烯基，氰基-C₃-C₆烯基，C₃-C₆卤代烯基，C₃-C₆炔基，氰基-C₃-C₆炔基，C₃-C₆卤代炔基，HO-CO-C₁-C₄烷基，(C₁-C₄烷氧基)CO-C₁-C₄烷基，(C₁-C₄烷基)CS-C₁-C₄烷基，H₂N-CO-C₁-C₄烷基，C₁-十一烷基-NHCO-C₁-C₄烷基，二(C₁-C₄烷基)NCO-C₁-C₄烷基，二(C₁-C₄烷基)磷酸基-C₁-C₄烷基，C₃-C₈环烷基（任选取代），C₃-C₈环烷基-C₁-C₄烷基，苯基，苯基-C₁-C₄烷基，3-至7-员杂环基或杂环基-C₁-C₄烷基，其中每个杂环基环可含一个CO-环键或CS-环键；或者，若Z=化学键，R₇还可为H，OH，CN，SH，NH₂，卤素，-CH(OH)-CH₂-R₉，-CH(卤素)-CH₂-R₉，-CH₂-CH(卤素)-R₉，-CH=CH-R₉或-CH=C(卤素)-R₉，其中R₉=COOH，(C₁-C₄烷氧基)羰基，(C₁-C₄烷硫基)羰基，CONH₂，C₁-C₄烷基-NHCO，或二(C₁-C₄烷基)NCO；或R₇+R₈=任选取代的1,3-丙二烯基，四亚甲基，五亚甲基或氧二亚甲基链。 （EN）发明涉及式(I)的3-(苯并杂环-4-基)嘧啶二酮衍生物及其盐，其中X=O，S；R₁=H，NH₂，C₁-C₆烷基，C₁-C₆卤代烷基；R₂=H，卤素，C₁-C₆烷基，C₁-C₆卤代烷基，C₁-C₆烷硫基，C₁-C₆亚磺酰基，C₁-C₆磺酰基；R₃=H，卤素，C₁-C₆烷基；R₄=H，卤素；R₅=CN，卤素，C₁-C₆烷基，C₁-C₆卤代烷基，C₁-C₆烷氧基，C₁-C₆卤代烷氧基；=Y-为=N-N(R₆)-，=C(ZR₇)-N(R₆)-，=C(ZR₇)-O-，=C(ZR₇)-S-；R₆=C₁-C₆烷基，C₁-C₄卤代烷基，C₃-C₆环烷基，C₃-C₆烯基，C₃-C₆炔基，C₁-C₆烷基-SO₂，C₁-C₆烷基-CO，C₁-C₆卤代烷基-CO，C₁-C₆烷基-CS，C₁-C₆烷氧基-CO，C₁-C₆烷氧基-CS或C₁-C₆烷基（任选取代）；Z=化学键，O，S，-S(O)-，-SO₂-，-NH-，-N(R₈)-；R₇，R₈=C₁-C₆烷基，C₁-C₆卤代烷基，羟基-C₁-C₄烷基，氰基-C₁-C₄烷基，C₁-C₄烷氧基-C₁-C₄烷基，C₁-C₄卤代烷氧基-C₁-C₄烷基，C₃-C₄烯氧基-C₁-C₄烷基，C₃-C₄炔氧基-C₁-C₄烷基，C₃-C₈环烷氧基-C₁-C₄烷基，氨基-C₁-C₄烷基，C₁-C₄烷氨基-C₁-C₄烷基，二(C₁-C₄烷基)氨基-C₁-C₄烷基，C₁-C₄烷硫基-C₁-C⁻烷基，C₁-C₄卤代烷硫基-C₁-C₄烷基，C₃-C₄烯硫基-C₁-C₄烷基，C₃-C₄炔硫基-C₁-C₄烷基，C₁-C₄烷亚磺基-C₁-C₄烷基，C₁-C₄卤代烷亚磺基-C₁-C₄烷基，C₃-C₄烯亚磺基-C₁-C₄烷基，C₃-C₄炔亚磺基-C₁-C₄烷基，C₁-C₄烷磺基-C₁-C₄烷基，C₁-C₄卤代烷磺基-C₁-C₄烷基，C₃-C₄烯磺基-C₁-C₄烷基，C₃-C₄炔磺基-C₁-C₄烷基，C₃-C₆烯基，氰基-C₃-C₆烯基，C₃-C₆卤代烯基，C₃-C₆炔基，氰基-C₃-C₆炔基，C₃-C₆卤代炔基，HO-CO-C₁-C₄烷基，(C₁-C₄烷氧基)CO-C₁-C₄烷基，(C₁-C₄烷基)CS-C₁-C₄烷基，H₂N-CO-C₁-C₄烷基，C₁-C₄烷基-NHCO-C₁-C₄烷基，二(C₁-C₄烷基)NCO-C₁-C₄烷基，二(C₁-C₄烷基)磷酸基-C₁-C₄烷基，C₃-C₈环烷基（任选取代），C₃-C₈环烷基-C₁-C₄烷基，苯基，苯基-C₁-C₄烷基，3-至7-员杂环基或杂环基-C₁-C₄烷基，其中每个杂环基环可含一个CO-环键或CS-环键；或者，若Z=化学键，R₇还可为H，OH，CN，SH，NH₂，卤素，-CH(OH)-CH₂-R₉，-CH(卤素)-CH₂-R₉，-CH₂-CH(卤素)-R₉，-CH=CH-R₉或-CH=C(卤素)-R₉，其中R₉=COOH，(C₁-C₄烷氧基)羰基，(C₁-C₄烷硫基)羰基，CONH₂，C₁-C₄烷基-NHCO，或二(C₁-C₄烷基)NCO；或R₇+R₈=任选取代的1,3-丙二烯基，四亚甲基，五亚甲基或氧二亚甲基链。 （FR）发明涉及式(I)的3-(苯并杂环-4-基)嘧啶二酮衍生物及其盐，其中X=O，S；R₁=H，NH₂，C₁-C₆烷基，C₁-C₆卤代烷基；R₂=H，卤素，C₁-C₆烷基，C₁-C₆卤代烷基，C₁-C₆烷硫基，C₁-C₆亚磺酰基，C₁-C₆磺酰基；R₃=H，卤素，C₁-C₆烷基；R₄=H，卤素；R₅=CN，卤素，C₁-C₆烷基，C₁-C₆卤代烷基，C₁-C₆烷氧基，C₁-C₆卤代烷氧基；=Y-为=N-N(R₆)-，=C(ZR₇)-N(R₆)-，=C(ZR₇)-O-，=C(ZR₇)-S-；R₆=C₁-C₆烷基，C₁-C₄卤代烷基，C₃-C₆环烷基，C₃-C₆烯基，C₃-C₆炔基，C₁-C₆烷基-SO₂，C₁-C₆烷基-CO，C₁-C₆卤代烷基-CO，C₁-C₆烷基-CS，C₁-C₆烷氧基-CO，C₁-C₆烷氧基-CS或C₁-C₆烷基（任选取代）；Z=化学键，O，S，-S(O)-，-SO₂-，-NH-，-N(R₈)-；R₇，R₈=C₁-C₆烷基，C₁-C₆卤代烷基，羟基-C₁-C₄烷基，氰基-C₁-C₄烷基，C₁-C₄烷氧基-C₁-C₄烷基，C₁-C₄卤代烷氧基-C₁-C₄烷基，C₃-C₄烯氧基-C₁-C₄烷基，C₃-C₄炔氧基-C₁-C₄烷基，C₃-C₈环烷氧基-C₁-C₄烷基，氨基-C₁-C₄烷基，C₁-C₄烷氨基-C₁-C₄烷基，二(C₁-C₄烷基)氨基-C₁-C₄烷基，C₁-C₄烷硫基-C₁-C₄烷基，C₁-C₄卤代烷硫基-C₁-C₄烷基，C₃-C₄烯硫基-C₁-C₄烷基，C₃-C₄炔硫基-C₁-C₄烷基，C₁-C₄烷亚磺基-C₁-C₄烷基，C₁-C₄卤代烷亚磺基-C₁-C₄烷基，C₃-C₄烯亚磺基-C₁-C₄烷基，C₃-C₄炔亚磺基-C₁-C₄烷基，C₁-C₄烷磺基-C₁-C₄烷基，C₁-C₄卤代烷磺基-C₁-C₄烷基，C₃-C₄烯磺基-C₁-C₄烷基，C₃-C₄炔磺基-C₁-C₄烷基，C₃-C₆烯基，氰基-C₃-C₆烯基，C₃-C₆卤代烯基，C₃-C₆炔基，氰基-C₃-C₆炔基，C₃-C₆卤代炔基，HO-CO-C₁-C₄烷基，(C₁-C₄烷氧基)CO-C₁-C₄烷基，(C₁-C₄烷基)CS-C₁-C₄烷基，H₂N-CO-C₁-C₄烷基，C₁-C₄烷基-NHCO-C₁-C₄烷基，二(C₁-C₄烷基)NCO-C₁-C₄烷基，二(C₁-C₄烷基)磷酸基-C₁-C₄烷基，C₃-C₈环烷基（任选取代），C₃-C₈环烷基-C₁-C₄烷基，苯基，苯基-C₁-C₄烷基，3-至7-员杂环基或杂环基-C₁-C₄烷基，其中每个杂环基环可含一个CO-环键或CS-环键；或者，若Z=化学键，R₇还可为H，OH，CN，SH，NH₂，卤素，-CH(OH)-CH₂-R₉，-CH(卤素)-CH₂-R₉，-CH₂-CH(卤素)-R₉，-CH=CH-R₉或-CH=C(卤素)-R₉，其中R₉=COOH，(C₁-C₄烷氧基)羰基，(C₁-C₄烷硫基)羰基，CONH₂，C₁-C₄烷基-NHCO，或二(C₁-C₄烷基)NCO；或R₇+R₈=任选取代的1,3-丙二烯基，四亚甲基，五亚甲基或氧二亚甲基链。
• USRE039590E1
  申请人：——

  公开号：——

  公开（公告）日：——
• HERBIZIDE 3-(BENZAZOL-4-YL)PYRIMIDINDION-DERIVATE
  申请人：BASF AKTIENGESELLSCHAFT

  公开号：EP1047693A1

  公开（公告）日：2000-11-02